Excess Neuropeptides Disrupt Lung Function in Infant Disease and COVID-19

UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.

Click here to view original post